Patents by Inventor Elliot Kieff

Elliot Kieff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040138418
    Abstract: The present invention relates, in general, to Epstein Barr Virus induced (EBI) genes. In particular, the present invention relates to DNA segments coding for EBI 1, EBI 2, or EBI 3 polypeptide; EBI 1, EBI 2, or EBI 3 polypeptide; recombinant DNA molecules; cells containing the recombinant DNA molecules; antisense EBI 1, EBI 2, or EBI 3 constructs; antibodies having binding affinity to an EBI 2, EBI 2, or EBI 3 polypeptide; hybridomas containing the antibodies; nucleic acid probes for the detection of the presence of Epstein Barr Virus; a method for detecting Epstein Barr Virus in a sample; and kits containing nucleic acid probes or antibodies.
    Type: Application
    Filed: December 31, 2003
    Publication date: July 15, 2004
    Applicant: The Brigham and Women's Hospital, Inc.
    Inventors: Mark Birkenbach, Elliot Kieff
  • Patent number: 6699971
    Abstract: The present invention relates, in general, to Epstein Barr virus induced (EBI) genes. In particular, the present invention relates to DNA segments coding for EBI 1, EBI 2, or EBI 3 polypeptides; EBI 1, EBI 2, or EBI 3 polypeptides; recombinant DNA molecules; cells containing the recombinant DNA molecules; antisense EBI 1, EBI 2, or EBI 3 constructs; antibodies having binding affinity to an EBI 1, EBI 2, or EBI 3 polypeptide; hybridomas containing the antibodies; nucleic acid probes for the detection of the presence of Epstein Barr Virus; a method of detecting Epstein Barr virus in a sample; and kits containing nucleic acid probes or antibodies.
    Type: Grant
    Filed: August 14, 2001
    Date of Patent: March 2, 2004
    Assignee: The Brigham & Women's Hospital, Inc.
    Inventors: Mark Birkenbach, Elliot Kieff
  • Patent number: 6500926
    Abstract: The present invention relates, in general, to Epstein Barr virus induced (EBI) genes. In particular, the present invention relates to DNA segments coding for EBI 1, EBI 2, or EBI 3 polypeptides; EBI 1, EBI 2, or EBI 3 polypeptides; recombinant DNA molecules; cells containing the recombinant DNA molecules; antisense EBI 1, EBI 2, or EBI 3 constructs; antibodies having binding affinity to an EBI 1, EBI 2, or EBI 3 polypeptide; hybridomas containing the antibodies; nucleic acid probes for the detection of the presence of Epstein Barr Virus; a method of detecting Epstein Barr virus in a sample; and kits containing nucleic acid probes or antibodies.
    Type: Grant
    Filed: March 28, 2000
    Date of Patent: December 31, 2002
    Assignee: The Brigham & Women's Hospital, Inc.
    Inventors: Mark Birkenbach, Elliot Kieff
  • Publication number: 20020040133
    Abstract: The present invention relates, in general, to Epstein Barr virus induced (EBI) genes. In particular, the present invention relates to DNA segments coding for EBI 1, EBI 2, or EBI 3 polypeptides; EBI 1, EBI 2, or EBI 3 polypeptides; recombinant DNA molecules; cells containing the recombinant DNA molecules; antisense EBI 1, EBI 2, or EBI 3 constructs; antibodies having binding affinity to an EBI 1, EBI 2, or EBI 3 polypeptide; hybridomas containing the antibodies; nucleic acid probes for the detection of the presence of Epstein Barr Virus; a method of detecting Epstein Barr virus in a sample; and kits containing nucleic acid probes or antibodies.
    Type: Application
    Filed: August 14, 2001
    Publication date: April 4, 2002
    Inventors: Mark Birkenbach, Elliot Kieff
  • Patent number: 6043351
    Abstract: The present invention relates, in general, to Epstein Barr virus induced (EBI) genes. In particular, the present invention relates to DNA segments coding for EBI 1, EBI 2, or EBI 3 polypeptides; EBI 1, EBI 2, or EBI 3 polypeptides; recombinant DNA molecules; cells containing the recombinant DNA molecules; antisense EBI 1, EBI 2, or EBI 3 constructs; antibodies having binding affinity to an EBI 1, EBI 2, or EBI 3 polypeptide; hybridomas containing the antibodies; nucleic acid probes for the detection of the presence of Epstein Barr Virus; a method of detecting Epstein Barr virus in a sample; and kits containing nucleic acid probes or antibodies.
    Type: Grant
    Filed: November 30, 1994
    Date of Patent: March 28, 2000
    Assignee: Brigham and Women's Hospital
    Inventors: Mark Birkenbach, Elliot Kieff